C-polysaccharide in a pneumococcal vaccine

Acta Pathol Microbiol Immunol Scand C. 1984 Dec;92(6):351-6. doi: 10.1111/j.1699-0463.1984.tb00099.x.

Abstract

The 14-valent pneumococcal vaccine, Pneumovax, was found to contain approximately 25o micrograms per ml of the cell-wall antigen, C-polysaccharide (C-Ps), in addition to 100 micrograms per ml of each of the 14 capsular polysaccharides. Rabbit anti-C-Ps antiserum recognized four components of this C-Ps with different antigenic determinants, corresponding to four fragments with different molecular sizes. By lectin affinity chromatography it was demonstrated that some of the C-Ps in the vaccine contained cell-wall residues. The methods used in this study can also be used for the characterization of other polysaccharide preparations.

Publication types

  • Comparative Study

MeSH terms

  • Antigens, Bacterial / analysis
  • Bacterial Vaccines / analysis*
  • Epitopes / analysis
  • Pneumococcal Vaccines
  • Polysaccharides, Bacterial / analysis*
  • Streptococcus pneumoniae / immunology*

Substances

  • Antigens, Bacterial
  • Bacterial Vaccines
  • Epitopes
  • Pneumococcal Vaccines
  • Polysaccharides, Bacterial
  • polysaccharide C-substance (Streptococcus)